Cargando…
From rapalogs to anti-aging formula
Inhibitors of mTOR, including clinically available rapalogs such as rapamycin (Sirolimus) and Everolimus, are gerosuppressants, which suppress cellular senescence. Rapamycin slows aging and extends life span in a variety of species from worm to mammals. Rapalogs can prevent age-related diseases, inc...
Autor principal: | Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482593/ https://www.ncbi.nlm.nih.gov/pubmed/28548953 http://dx.doi.org/10.18632/oncotarget.18033 |
Ejemplares similares
-
Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
por: Blagosklonny, Mikhail V.
Publicado: (2012) -
Rejuvenating immunity: “anti-aging drug today” eight years later
por: Blagosklonny, Mikhail V.
Publicado: (2015) -
MTOR-driven quasi-programmed aging as a disposable soma theory: Blind watchmaker vs. intelligent designer
por: Blagosklonny, Mikhail V.
Publicado: (2013) -
Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023) -
Are menopause, aging and prostate cancer diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023)